Restoring Function in Exhausted CD8 T Cells During Chronic Viral Infection
Authors
Affiliations
Functional impairment of antigen-specific T cells is a defining characteristic of many chronic infections, but the underlying mechanisms of T-cell dysfunction are not well understood. To address this question, we analysed genes expressed in functionally impaired virus-specific CD8 T cells present in mice chronically infected with lymphocytic choriomeningitis virus (LCMV), and compared these with the gene profile of functional memory CD8 T cells. Here we report that PD-1 (programmed death 1; also known as Pdcd1) was selectively upregulated by the exhausted T cells, and that in vivo administration of antibodies that blocked the interaction of this inhibitory receptor with its ligand, PD-L1 (also known as B7-H1), enhanced T-cell responses. Notably, we found that even in persistently infected mice that were lacking CD4 T-cell help, blockade of the PD-1/PD-L1 inhibitory pathway had a beneficial effect on the 'helpless' CD8 T cells, restoring their ability to undergo proliferation, secrete cytokines, kill infected cells and decrease viral load. Blockade of the CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitory pathway had no effect on either T-cell function or viral control. These studies identify a specific mechanism of T-cell exhaustion and define a potentially effective immunological strategy for the treatment of chronic viral infections.
Chen H, Kim N, Nishizaki D, Nesline M, Conroy J, DePietro P NPJ Genom Med. 2025; 10(1):21.
PMID: 40069238 PMC: 11897377. DOI: 10.1038/s41525-025-00465-9.
Deecke L, Ohlei O, Goldeck D, Homann J, Toepfer S, Demuth I Cells. 2025; 14(4).
PMID: 39996723 PMC: 11852917. DOI: 10.3390/cells14040250.
Functional memory T cells are derived from exhausted clones and expanded by checkpoint blockade.
Raposo C, Yan P, Chen A, Majidi S, Hiam-Galvez K, Satpathy A bioRxiv. 2025; .
PMID: 39990338 PMC: 11844384. DOI: 10.1101/2025.02.10.637523.
Hilt Z, Reynaldi A, Steinhilber M, Zhang S, Wesnak S, Smith N bioRxiv. 2025; .
PMID: 39975271 PMC: 11839080. DOI: 10.1101/2025.02.06.636722.
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.
Strati A, Adamopoulos C, Kotsantis I, Psyrri A, Lianidou E, Papavassiliou A Int J Mol Sci. 2025; 26(3).
PMID: 39941003 PMC: 11818137. DOI: 10.3390/ijms26031235.